Landscape Capital Management’s La Jolla Pharmaceutical Company LJPC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-16,392
Closed -$488K 604
2017
Q2
$488K Hold
16,392
0.06% 200
2017
Q1
$489K Buy
+16,392
New +$419K 0.05% 305
2016
Q3
Sell
-53,254
Closed -$852K 697
2016
Q2
$852K Sell
53,254
-2,346
-4% -$42.1K 0.11% 206
2016
Q1
$1.16M Buy
55,600
+11,137
+25% +$199K 0.14% 206
2015
Q4
$1.2M Buy
44,463
+32,563
+274% +$888K 0.15% 167
2015
Q3
$331K Buy
+11,900
New +$375K 0.05% 435

Other funds holding LJPC

Landscape Capital Management's LJPC Position: Q3 2017 in Review

Landscape Capital Management sold out of La Jolla Pharmaceutical Company (LJPC) in Q3 2017, closing a stake of 16,392 shares — an estimated $488K sold.

Landscape Capital Management first reported a position in LJPC in Q3 2015 and held it in 6 quarters. The position peaked at $1.2M in Q4 2015. 95 funds tracked by Wall St. Rank hold LJPC as of Q3 2017.

  • Landscape Capital Management reported no remaining La Jolla Pharmaceutical Company position as of Q3 2017 after selling out during the quarter.
  • Landscape Capital Management sold 16,392 La Jolla Pharmaceutical Company shares in Q3 2017, an estimated $488K.
  • Landscape Capital Management first reported a position in La Jolla Pharmaceutical Company in Q3 2015 and held it in 6 quarters.
  • Landscape Capital Management's La Jolla Pharmaceutical Company position peaked at $1.2M in Q4 2015.
  • 95 funds tracked by Wall St. Rank held La Jolla Pharmaceutical Company as of Q3 2017.

Based on Landscape Capital Management's 13F filing for Q3 2017, filed 14 Nov 2017.